{"id":141266,"date":"2024-12-23T12:36:21","date_gmt":"2024-12-23T07:06:21","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=141266"},"modified":"2024-12-23T12:36:24","modified_gmt":"2024-12-23T07:06:24","slug":"pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/","title":{"rendered":"Pharma stock jumps after getting approval from UK&#8217;s MHRA for its cancer drug\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3084126108\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the &#8220;cancer capital of the world.&#8221; Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-121538415\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>In response, Indian pharma companies are ramping up research and development efforts to produce affordable and effective cancer treatments. By focusing on targeted therapies and generics, these companies aim to make life-saving medications accessible to a larger population, addressing the growing cancer burden in the country.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price&nbsp;<\/strong><\/h2><p>The shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AUROPHARMA\" target=\"_blank\" rel=\"noreferrer noopener\">Aurobindo Pharma<\/a><\/strong> are currently trading at Rs. 1,260.6 up by 1.52% from its previous close of Rs. 1,241.7 as of December 23, 2024. The stock also touched an intraday high of Rs. 1,265.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Updates&nbsp;<\/strong><\/h2><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Approval of Bevqolva for Cancer Treatment&nbsp;<\/strong><\/h2><p>CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has received approval from the UK&#8217;s Medicines and Healthcare Products Regulatory Agency (MHRA) to market its biosimilar version of bevacizumab, called Bevqolva. This drug is used to treat various types of cancer, including colorectal, lung, kidney, cervical, and ovarian cancers. The approval allows Bevqolva to be available in 25 mg\/mL concentration for infusion, offered in two vial sizes: 4 mL (100 mg) and 16 mL (400 mg), both designed for vein infusion.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-4113586849\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Affordable Treatment Option for Cancer Patients&nbsp;<\/strong><\/h2><p>Bevqolva is a biosimilar to the brand-name drug Avastin and is intended to provide a more affordable option for patients undergoing cancer treatment. Its approval marks an important step in expanding treatment choices for those battling several types of serious cancers.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About CuraTeQ Biologics&nbsp;<\/strong><\/h2><p>CuraTeQ Biologics Private Limited (CuraTeQ), a subsidiary of Aurobindo Pharma Limited, is a global biopharmaceutical company headquartered in Hyderabad, India. CuraTeQ\u2019s vision is to improve the well-being of patients suffering from debilitating illnesses by providing them access to high-quality and cost-effective biosimilars.&nbsp;<\/p><p>It is focused on developing biosimilars for the treatment of various cancers and autoimmune diseases. CuraTeQ&#8217;s pipeline consists of fourteen biosimilars, primarily targeting the immunology and oncology segments. It has end-to-end capabilities in producing a full range of products from bulk drug substance to fill finish and packaged drug products.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About Aurobindo Pharma<\/strong><\/h2><p>Aurobindo Pharma Limited, headquartered in Hyderabad, India, is a leading global pharmaceutical company. It develops, manufactures, and markets a wide range of generic drugs, branded specialty pharmaceuticals, and active pharmaceutical ingredients across more than 150 countries.&nbsp;<\/p><p>The company operates 29 manufacturing and packaging facilities approved by top regulatory agencies such as the USFDA, UK MHRA, and Japan PMDA. Aurobindo&#8217;s diverse product portfolio spans several therapeutic areas, including CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterology, Anti-Diabetics, and Anti-Allergic.&nbsp;<\/p><p>The company is backed by a strong research and development setup, enabling continued growth and innovation in the pharmaceutical industry.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-3478237050\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By: Dipangshu Kundu&nbsp;<\/strong><\/p><\/blockquote><\/blockquote><\/blockquote><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1009704094\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the &#8220;cancer capital of the world.&#8221; Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.&nbsp; [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25691,9217,25690,948,936],"class_list":["post-141266","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-aurobindo-pharma-cancer-drug-approval","tag-aurobindo-pharma-latest-news","tag-aurobindo-pharma-limited","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps after getting approval from UK&#039;s MHRA for its cancer drug\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the &quot;cancer capital of the world.&quot; Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps after getting approval from UK&#039;s MHRA for its cancer drug\u00a0\" \/>\n<meta property=\"og:description\" content=\"Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the &quot;cancer capital of the world.&quot; Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-23T07:06:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-23T07:06:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/\",\"name\":\"Pharma stock jumps after getting approval from UK's MHRA for its cancer drug\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-12-23T07:06:21+00:00\",\"dateModified\":\"2024-12-23T07:06:24+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the \\\"cancer capital of the world.\\\" Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps after getting approval from UK&#8217;s MHRA for its cancer drug\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps after getting approval from UK's MHRA for its cancer drug\u00a0 - Trade Brains Features","description":"Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the \"cancer capital of the world.\" Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps after getting approval from UK's MHRA for its cancer drug\u00a0","og_description":"Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the \"cancer capital of the world.\" Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-23T07:06:21+00:00","article_modified_time":"2024-12-23T07:06:24+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/","name":"Pharma stock jumps after getting approval from UK's MHRA for its cancer drug\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-12-23T07:06:21+00:00","dateModified":"2024-12-23T07:06:24+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Cancer drug pharmaceutical companies play a crucial role in developing innovative therapies to combat the rising incidence of cancer globally. As India faces a significant increase in cancer cases, experts predict it may become the \"cancer capital of the world.\" Factors such as lifestyle changes, environmental pollution, and genetic predisposition contribute to this alarming trend.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-getting-approval-from-uks-mhra-for-its-cancer-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps after getting approval from UK&#8217;s MHRA for its cancer drug\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=141266"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141266\/revisions"}],"predecessor-version":[{"id":141267,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141266\/revisions\/141267"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=141266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=141266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=141266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}